President Donald Trump speaks before signing an executive order on fraud in the Oval Office at the White House in Washington, D.C., on March 16, 2026, as Vice President JD Vance looks on. (Photo by ...

In June, Gov. Josh Shapiro spoke to those gathered at the Jackson Mansion in Berwick with the announcement of Amazon data centers coming to the Keystone State. AP File Photo More than 100 residents ...

Ingo Swann participated in classified experiments involving remote viewing. According to his account, he observed structures on the Moon. ‘By the hour’: Fresh fuel blow to Aussies US military presence ...

The Bachelor of Science in Data Analytics is a new interdisciplinary program designed to prepare you with the skills to collect, manage, analyze and interpret complex data. Building on foundations in ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

WASHINGTON — SpaceX has acquired xAI, an artificial intelligence company also run by Elon Musk, as part of his effort to develop orbital data centers. In a statement Feb. 2, SpaceX said it acquired ...

Spire Global has won contracts to provide the National Oceanic and Atmospheric Administration's Commercial Weather Data Program with global navigation satellite system (GNSS) radio occultation and ...

Integrating artificial intelligence into business areas, adopting global AI-based platforms, and building a robust ecosystem with technological partnerships—these were the three pillars on which ...

Loyalty programs were once designed to thank customers for sticking around. This could include perks like free coffee, airline miles, or grocery discounts in exchange for repeat business. But that ...

Store loyalty programs used to be simple: You’d get a punch card at a local sub shop, buy eight sandwiches and get your ninth for free. It felt like a transparent “thank you” for your business. But ...

Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...